Browse by all authors Browse By Author Name - Bowler,+S.+D.

Browse Results (11 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Shiels, I. A., Bowler, S. D. and Taylor, S. M. (1995) Airway smooth muscle proliferation in asthma: The potential of vascular leakage to contribute to pathogenesis. Medical Hypothesis, 45 1: 37-40. doi:10.1016/0306-9877(95)90198-1 49   17 Cited 17 times in Scopus17 0
Wolter, J. M., Bowler, S. D. and McCormack, J. G. (1999) Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?. Australian and New Zealand Journal of Medicine, 1 1: 15-21. doi:10.1111/j.1445-5994.1999.tb01583.x 69   13 0
Wolter, J. M., Seeney, S. L., Yang, I. A., Bowler, S. D., Bell, S. and Mccormack, J. G. (2000). Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF). In: Abstracts of the ASID Annual Scientific Meeting. ASID Annual Scientific Meeting, Laura, NSW, (422-422). 15-19 April, 2001. 83  
Bell, S., Wolter, J. M., Seeney, S. L., Gan, R., Yang, I., Bowler, S. D. and Mccormack, J. G. (2000). Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis. In: Gerd J. A Cropp and Editorial Board, Proceedings of the 2000 Cystic Fibrosis Conference. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, (261). 9-12 Novembe, 2000. 85  
Serisier, D. J., Singh, M. and Bowler, S. D. (2005) Bronchial beetle. Thorax, 60 3: 262-262. doi:10.1136/thx.2004.037770 16   0 Cited 0 times in Scopus0 0
Bell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. In: Pediatric pulmonology: Abstracts of the 16th Annual North American Cystic Fibrosis Conference. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, (289-289). 3-6 October, 2002. doi:10.1002/ppul.70010 140   0
Bowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. In: Respirology: Abstracts of the TSANZ 2002 Annual Scientific Meeting. Respirology. TSANZ Annual Scientific Meeting, Cairns, Queensland, (A9-A9). 22-27 March, 2002. doi:10.1111/j.1440-1843.2004.supp_1.x 115   0
McIntyre, H. D., Mitchell, C. A., Bowler, S. D., Armstrong, J. G., Wooler, J. A. and Cowley, D. M. (1995) Measuring the systemic effects of inhaled beclomethasone: Timed morning urine collections compared with 24 hour specimens. Thorax, 50 12: 1280-1284. doi:10.1136/thx.50.12.1280 34   51 Cited 47 times in Scopus47 0
Serisier, D. J. and Bowler, S. D. (2012) Randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis . . . without patient blinding. American Journal of Respiratory and Critical Care Medicine, 186 5: 461-461. 35   1 Cited 0 times in Scopus0
Shiels, I. A., Bowler, S. D. and Taylor, S. M. (1999) The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells. Inflammation, 23 4: 321-331. doi:10.1023/A:1020257532357 125   10 Cited 66 times in Scopus66 0
Gan, R., Bowler, S. D., Seeney, S. L., Wolter, J.M., Masel, P. J., Bunting, J., Tunnicliffe, A. M., Rabnott, G. C., Yang, I. A. and Bell, S. (2000). Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.. In: Gerd J. A .Cropp and Editorial Board, Abstracts of the 2000 Cystic Fibrosis Conference. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, (261-261). 9-12 Novewmber, 2000. 53